KK

Active Director Director DIN 09706742
DIN 09706742 First appointment Aug 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Kale Khan

Data last updated:

Kale Khan is a Director at Uzwi Healthcare Private Limited (since 2022). The company operates in Chemicals. Uzwi Healthcare Private Limited reported revenue of ₹2.7 Lakh (FY 2024).

DIN 09706742
Primary Designation Director
Industry Chemicals
First Appointment 18 Aug 2022
Oldest Company Age 4 yrs
Largest company Uzwi Healthcare Private Limited · ₹2.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Uzwi Healthcare Private Limited U24231MP2022PTC062279
Director18 Aug 20222022₹2.7 Lakh (FY 2024)Active

Board colleagues of Kale Khan

NameDINCompanyDesignation
Mohd Aftab Khan09706743Uzwi Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Uzwi Healthcare Private Limited
Premium access

Shareholding and investment profile for Kale Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kale Khan

Kale Khan currently holds 1 directorship: Uzwi Healthcare Private Limited (Director, since 18 Aug 2022, revenue ₹2.7 Lakh (FY 2024)).

Kale Khan was first appointed on 18 Aug 2022 as Director at Uzwi Healthcare Private Limited.

The current boards of Kale Khan's companies include Mohd Aftab Khan (Uzwi Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available